ISpecimen Net Income Per Share from 2010 to 2026
| ISPC Stock | USD 0.31 0.01 4.28% |
Net Loss | First Reported 2010-12-31 | Previous Quarter (15.82) | Current Value (16.61) | Quarterly Volatility 45.40554782 |
Check ISpecimen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ISpecimen's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Interest Income of 89.1 K or Interest Expense of 188.2 K, as well as many indicators such as Price To Sales Ratio of 0.22, Dividend Yield of 0.0 or PTB Ratio of 0.33. ISpecimen financial statements analysis is a perfect complement when working with ISpecimen Valuation or Volatility modules.
ISpecimen | Net Income Per Share | Build AI portfolio with ISpecimen Stock |
Analyzing ISpecimen's Net Income Per Share over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income Per Share has evolved provides context for assessing ISpecimen's current valuation and future prospects.
Latest ISpecimen's Net Income Per Share Growth Pattern
Below is the plot of the Net Income Per Share of iSpecimen over the last few years. It is ISpecimen's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ISpecimen's overall financial position and show how it may be relating to other accounts over time.
| Net Income Per Share | 10 Years Trend |
|
Net Income Per Share |
| Timeline |
ISpecimen Net Income Per Share Regression Statistics
| Arithmetic Mean | (79.24) | |
| Coefficient Of Variation | (57.30) | |
| Mean Deviation | 41.85 | |
| Median | (114.11) | |
| Standard Deviation | 45.41 | |
| Sample Variance | 2,062 | |
| Range | 98.2943 | |
| R-Value | 0.87 | |
| Mean Square Error | 548.95 | |
| R-Squared | 0.75 | |
| Slope | 7.79 | |
| Total Sum of Squares | 32,987 |
ISpecimen Net Income Per Share History
About ISpecimen Financial Statements
ISpecimen stakeholders use historical fundamental indicators, such as ISpecimen's Net Income Per Share, to determine how well the company is positioned to perform in the future. Although ISpecimen investors may analyze each financial statement separately, they are all interrelated. For example, changes in ISpecimen's assets and liabilities are reflected in the revenues and expenses on ISpecimen's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in iSpecimen. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Loss | (15.82) | (16.61) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether iSpecimen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ISpecimen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ispecimen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ispecimen Stock:Check out the analysis of ISpecimen Correlation against competitors. For information on how to trade ISpecimen Stock refer to our How to Trade ISpecimen Stock guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Will Biotechnology sector continue expanding? Could ISpecimen diversify its offerings? Factors like these will boost the valuation of ISpecimen. Market participants price ISpecimen higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every ISpecimen data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (7.82) | Revenue Per Share | Quarterly Revenue Growth (0.96) | Return On Assets | Return On Equity |
The market value of iSpecimen is measured differently than its book value, which is the value of ISpecimen that is recorded on the company's balance sheet. Investors also form their own opinion of ISpecimen's value that differs from its market value or its book value, called intrinsic value, which is ISpecimen's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because ISpecimen's market value can be influenced by many factors that don't directly affect ISpecimen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ISpecimen's value and its price as these two are different measures arrived at by different means. Investors typically determine if ISpecimen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, ISpecimen's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.